NCT07466069 Lifestyle Intervention for Obesity and Eating Disorder Prevention in Transgender Adolescents
| NCT ID | NCT07466069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo |
| Condition | Obesity & Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2026-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2026-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Transgender and gender-diverse adolescents are at increased risk for obesity, disordered eating behaviors, body dissatisfaction, and reduced quality of life due to minority stress and structural inequities. However, no structured lifestyle interventions specifically tailored to this population have been developed. This randomized controlled trial aims to evaluate the effectiveness of a 6-month interdisciplinary lifestyle intervention designed to prevent obesity and eating disorders in transgender and gender-diverse adolescents aged 10-14 years. Participants will be randomized (1:1) to either an intervention group receiving monthly group sessions (for adolescents and caregivers separately) and weekly supportive messages, or a control group receiving standard outpatient care and general health recommendations. The primary outcome is quality of life measured by the WHOQOL-BREF. Secondary outcomes include eating disorder symptoms, body image, diet quality, physical activity levels, sedentary behavior, body composition, and anthropometric measures.
Eligibility Criteria
Inclusion Criteria: * Aged 10-14 years * Self-identified as transgender or gender-diverse Exclusion Criteria: * Current diagnosis of eating disorder requiring specialized treatment * Severe psychiatric instability * Cognitive impairment limiting participation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07466069 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 14 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07466069 currently recruiting?
Yes, NCT07466069 is actively recruiting participants. Contact the research team at gualano@usp.br for enrollment information.
Where is the NCT07466069 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT07466069 clinical trial?
NCT07466069 is sponsored by University of Sao Paulo. The trial plans to enroll 24 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.